Andrew Obenshain is Chief Executive Officer of bluebird bio, Inc. (BLUE). The company reported total compensation of $3,049,181 for fiscal year 2023.
| Salary | $681,657 |
|---|---|
| Bonus | $0 |
| Stock awards | $863,590 |
| Option awards | $1,142,440 |
| Non-equity incentive plan | $348,024 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $13,470 |
| Total | $3,049,181 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure bluebird bio, Inc. filed September 26, 2024, accession 0001293971-24-000049.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2023 | Chief Executive Officer | $681,657 | $0 | $863,590 | $1,142,440 | $348,024 | $0 | $13,470 | $3,049,181 |
| FY2022 | Chief Executive Officer | $643,390 | $0 | $351,000 | $421,830 | $386,280 | $0 | $12,200 | $1,814,700 |
Totals as disclosed in each year's own compensation disclosure for bluebird bio, Inc..
| Named executive officer | Role | FY2023 total |
|---|---|---|
| Andrew Obenshain this page | Chief Executive Officer | $3,049,181 |
| Richard Colvin | Chief Medical Officer | $1,344,253 |
| Thomas Klima | Chief Commercial and Operating Officer | $1,329,535 |
The company's named executive officers for fiscal year 2023, and what it reported for each. See the full bluebird bio, Inc. compensation brief.
Andrew Obenshain's compensation sits inside bluebird bio, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.